Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangxinshi Tablet for Exercise Tolerance in Chronic Coronary Syndrome
NCT05978089Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
A Phase 4 trial of yangxinshi in Chronic Coronary Syndrome (CCS), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Started Nov 2023; status: recruiting.
02
Drugs
yangxinshi
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT05978089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05978089.